| Literature DB >> 26075220 |
Bin Yu1, Bin Zhang1, Wen-Bo Zhou1, Qiu-Wei Wang1, Pei Yuan1, Yu-Qi Yang1, Jing Kong1.
Abstract
It is well known that Down syndrome (DS) is a condition in which extra genetic material causes delays in the way a child develops, both mentally and physically. Intellectual disability is the foremost and most debilitating trait, which caused loss of cognitive abilities and the development of early onset Alzheimer's disease (AD). Ts65Dn mice were used in this study. We isolated the hippocampus. First, we used transmission scanning electron microscopy to directly observe the hippocampus and confirm if apoptosis had occurred. Second, we customized a PCR array with 53 genes, including several important genes related to cell apoptosis. Gene expression was detected by RT-PCR. There were varying degrees of changes characteristic of apoptosis in the hippocampus of Ts65Dn mice, which mainly included the following: nuclear membrane thinning, unevenly distributed chromosomes, the production of chromatin crescents, and pyknosis of the nuclei with some nuclear fragmentation. Meanwhile, three genes (API5, AIFM1, and NFκB1) showed changes of expression in the hippocampus of Ts65Dn mice compared with normal mice. Only NFκB1 expression was significantly increased, while the expressions of API5 and AIFM1 were notably decreased. The fold changes in the expression of API5, AIFM1, and NFκB1 were 11.55, 5.94, and 3.11, respectively. However, some well-known genes related to cell apoptosis, such as the caspase family, Bcl-2, Bad, Bid, Fas, and TNF, did not show changes in expression levels. The genes we found which were differentially expressed in the hippocampus of Ts65Dn mice may be closely related to cell apoptosis. PCR array technology can assist in the screening and identification of genes involved in apoptosis.Entities:
Mesh:
Year: 2015 PMID: 26075220 PMCID: PMC4436439 DOI: 10.1155/2015/214618
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The morphological changes in the hippocampus of Ts65Dn mice observed by TEM. (a) Normal hippocampus tissues in control mice showing typical synaptic and normal cell structure, including normal cell nuclear shapes, distributed chromatin, abundant organelles, dense mitochondria, and flat Golgi apparatus. (b) In Ts65Dn mice the nuclear membrane became thin, chromosomes appeared unevenly distributed, and chromatin crescents were produced. (c) The nuclei exhibited pyknosis and nuclear fragmentation. (d) The cell wall began to sag and cell atrophy was observed.
Differential apoptotic gene expressions in the hippocampus of Ts65Dn mice.
| Gene symbol | Description of genes | Chromosome | Ts65Dn/control group | ||
|---|---|---|---|---|---|
| Human | Mouse | Fold changes |
| ||
| API5 | Apoptosis inhibitor 5 | 11 | 2 | −11.55 | 0.00∗ |
| AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | X | X | −5.94 | 0.00∗ |
| NF | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 4 | 3 | 3.11 | 0.02∗ |
| Bcl-2 | B-cell CLL/lymphoma 2 | 18 | 1 | 2.75 | 0.07 |
| Ntrk1 | Neurotrophic tyrosine kinase, receptor, type 1 | 1 | 3 | 2.59 | 0.09 |
| Tnfrsf1a | Tumor necrosis factor receptor superfamily, member 1A | 12 | 6 | 2.52 | 0.1 |
| Ripk1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 | 6 | 13 | 2.52 | 0.1 |
| Rela | V-rel avian reticuloendotheliosis viral oncogene homolog A | 11 | 19 | 2.52 | 0.1 |
| Map3k14 | Mitogen-activated protein kinase kinase kinase 14 | 17 | 11 | 2.52 | 0.1 |
| Irak1 | Interleukin-1 receptor-associated kinase 1 | X | X | 2.52 | 0.1 |
| Il1a | Interleukin-1, alpha | 2 | 2 | 2.52 | 0.1 |
| Il10 | Interleukin 10 | 1 | 1 | 2.52 | 0.1 |
| Ikbkg | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | X | X | 2.52 | 0.1 |
| Ikbkb | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 8 | 8 | 2.52 | 0.1 |
| Igf1r | Insulin-like growth factor 1 receptor | 15 | 7 | 2.52 | 0.1 |
| Fadd | Fas (TNFRSF6)-associated via death domain | 11 | 7 | 2.52 | 0.1 |
| Dffa | DNA fragmentation factor, 45 kDa, alpha polypeptide | 1 | 4 | 2.52 | 0.1 |
| Dapk1 | Death-associated protein kinase 1 | 9 | 13 | 2.52 | 0.1 |
| Cideb | Cell death-inducing DFFA-like effector b | 14 | 14 | 2.52 | 0.1 |
| Cidea | Cell death-inducing DFFA-like effector a | 18 | 18 | 2.52 | 0.1 |
| Cdc2a | Cyclin-dependent kinase A-1 | 10 | 2.52 | 0.1 | |
| Cd70 | CD70 molecule | 19 | 17 | 2.52 | 0.1 |
| Casp-9 | Caspase-9 | 1 | 4 | 2.52 | 0.1 |
| Casp-8 | Caspase-8 | 2 | 1 | 2.52 | 0.1 |
| Casp-7 | Caspase-7 | 10 | 19 | 2.52 | 0.1 |
| Casp-6 | Caspase-6 | 4 | 3 | 2.52 | 0.1 |
| Casp-3 | Caspase-3 | 4 | 8 | 2.52 | 0.1 |
| Birc2 | Baculoviral IAP repeat containing 2 | 11 | 9 | 2.52 | 0.1 |
| Apaf1 | Apoptotic protease-activating factor 1 | 12 | 10 | 2.52 | 0.1 |
| Akt2 | V-akt murine thymoma viral oncogene homolog 2 | 19 | 7 | 2.52 | 0.1 |
| Akt3 | V-akt murine thymoma viral oncogene homolog 3 | 1 | 1 | 3.3 | 0.13 |
| Il1b | Interleukin-1, beta | 2 | 2 | 6.75 | 0.14 |
| Myd88 | Myeloid differentiation primary response gene 88 | 3 | 9 | 3.54 | 0.15 |
| Birc3 | Baculoviral IAP repeat containing 3 | 11 | 9 | 3.63 | 0.15 |
| Mapk3 | Mitogen-activated protein kinase 3 | 16 | 7 | 3.21 | 0.17 |
| Mapk1 | Mitogen-activated protein kinase 1 | 22 | 16 | 6.59 | 0.29 |
| Bid | BH3 interacting domain death agonist | 22 | 6 | −2.03 | 0.3 |
| Fas | Fas cell surface death receptor | 10 | 19 | 3.23 | 0.43 |
| Casp-4 | Caspase-4 | 11 | 9 | 1.7 | 0.48 |
| Akt1 | V-akt murine thymoma viral oncogene homolog 1 | 14 | 12 | 3.44 | 0.49 |
| TNF | Tumor necrosis factor | 6 | 17 | 2.01 | 0.5 |
| Nf | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 14 | 12 | 2 | 0.56 |
| Cd40lg | CD40 ligand | X | X | 1.64 | 0.61 |
| Pik3r2 | Phosphoinositide-3-kinase, regulatory subunit 2 | 19 | 8 | −1.64 | 0.72 |
| Casp-2 | Caspase-2 | 7 | 6 | −1.66 | 0.72 |
| Tnfrsf10b | Tumor necrosis factor receptor superfamily, member 10b | 8 | 14 | 1.49 | 0.75 |
| Ppp3cc | Protein phosphatase 3, catalytic subunit, gamma isozyme | 8 | 14 | 1.58 | 0.8 |
| Xiap | X-linked inhibitor of apoptosis | X | X | −1.05 | 0.85 |
| Ppp3r1 | Protein phosphatase 3, regulatory subunit B, alpha | 2 | 11 | 1.22 | 0.89 |
| Bad | Bcl-2-associated agonist of cell death | 11 | 19 | 1.15 | 0.9 |
| Pik3ca | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | 3 | 3 | 1.21 | 0.93 |
| Endog | Endonuclease G | 9 | 2 | 1.05 | 0.96 |
| Pik3cg | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 7 | 12 | −1.01 | 0.99 |
Note: ∗ P < 0.05.
Figure 2Fold change in gene expression between the Ts65Dn mice and the control group. Compared with the control group, the expression of API5 and AIFM1 showed decreased levels, and NFκB1 expression was increased in the hippocampal tissues of Ts65Dn mice.
Figure 3Comparison of the expressions of API5, AIFM1, and NFκB1 by Box plots. Box plots show the comparison of gene expression, calculated by 2-ΔΔCt, in Ts65Dn and the normal control group mice. Data were compared with t-tests. (a) API5. (b) AIFM1. (c) NFκB1.